Particulars |
|
|
|
Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
284.80 |
Sales(₹ Cr.) |
1,295.53 |
NP (₹ Cr.) |
149.06 |
NP Var% |
18.00 |
Div% |
1,200.00 |
CPS(₹) |
65.60 |
EPS (₹) |
59.60 |
Traded Value(₹ Lakhs) |
38.12 |
52 Week High |
7,550.00 |
52 Week Low |
4,050.00 |
Price BSE |
6,703.00 |
Price NSE |
6,716.00 |
Market Capital (₹ Cr.) |
16,757.50 |
P/C Ratio |
102.20 |
P/E Ratio |
112.40 |
Price Vs.BV |
23.54 |
|
Latest Quarter |
Year End |
202406 |
Sales (₹ Cr.) |
387.52 |
NP(₹ Cr.) |
35.02 |
NP Var % |
-35.00 |
Trailing Twelve Months |
Year End |
202406 |
Sales |
900.95 |
OPM |
18.03 |
NP |
92.12 |
NP Var% |
-20.53 |
EPS |
52.40 |
PE |
127.92 |
|
|